Litcius/Paper detail

5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)

Shankar Siva, Muhammad Ali, Rohann Correa, Alexander Muacevic, Lee Ponsky, Rodney J. Ellis, Simon S. Lo, Hiroshi Onishi, Anand Swaminath, Mark F. McLaughlin, Scott C. Morgan, Fabio Cury, Bin S. Teh, Anand Mahadevan, Irving Kaplan, William Chu, William Grubb, Raquibul Hannan, Michael Staehler, Andrew Warner, Alexander V. Louie

2022The Lancet Oncology133 citationsDOI

Topics & Concepts

SABR volatility modelMedicineRenal cell carcinomaRadiosurgeryCyberknifeRadiation therapyClinical endpointDiscontinuationUrologyInternal medicineSurgeryClinical trialEconomicsStochastic volatilityVolatility (finance)Financial economicsRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsHepatocellular Carcinoma Treatment and Prognosis